Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 123 entries
Sorted by: Best Match Show Resources per page
Nontransfemoral Approaches to Transcatheter Aortic Valve Replacement.

Interventional cardiology clinics

Murdock JE, Jensen HA, Thourani VH.
PMID: 28582125
Interv Cardiol Clin. 2015 Jan;4(1):95-105. doi: 10.1016/j.iccl.2014.09.006. Epub 2015 Feb 09.

Transcatheter aortic valve replacement (TAVR) is noninferior to surgical aortic valve replacement in patients with high operative risk and superior to medical treatment in patients deemed unsuitable for surgical intervention. However, up to 30% to 50% of patients screened...

Cite
Murdock JE, Jensen HA, Thourani VH. Nontransfemoral Approaches to Transcatheter Aortic Valve Replacement. Interv Cardiol Clin. 2015;4(1):95-105doi: 10.1016/j.iccl.2014.09.006.
Murdock, J. E., Jensen, H. A., & Thourani, V. H. (2015). Nontransfemoral Approaches to Transcatheter Aortic Valve Replacement. Interventional cardiology clinics, 4(1), 95-105. https://doi.org/10.1016/j.iccl.2014.09.006
Murdock, Jared E, et al. "Nontransfemoral Approaches to Transcatheter Aortic Valve Replacement." Interventional cardiology clinics vol. 4,1 (2015): 95-105. doi: https://doi.org/10.1016/j.iccl.2014.09.006
Murdock JE, Jensen HA, Thourani VH. Nontransfemoral Approaches to Transcatheter Aortic Valve Replacement. Interv Cardiol Clin. 2015 Jan;4(1):95-105. doi: 10.1016/j.iccl.2014.09.006. Epub 2015 Feb 09. PMID: 28582125.
Copy Download .nbib Format: NLM
Off-Pump Coronary Artery Bypass Grafting is Associated With Reduced Operative Mortality and In-Hospital Adverse Events in Patients With Left Main Coronary Artery Disease.

Innovations (Philadelphia, Pa.)

Sarin EL, Puskas JD, Kilgo PD, Thourani VH, Guyton RA, Lattouf OM.
PMID: 22436988
Innovations (Phila). 2009 Mar;4(2):80-5. doi: 10.1097/IMI.0b013e3181a20da6.

OBJECTIVE: : Left main coronary artery disease (LMD) is a known risk factor for perioperative complications. This study compares off-pump coronary artery bypass (OPCAB) versus on-pump coronary artery bypass (ONCAB) grafting, CABG, with respect to in-hospital death, stroke, myocardial...

Cite
Sarin EL, Puskas JD, Kilgo PD, et al. Off-Pump Coronary Artery Bypass Grafting is Associated With Reduced Operative Mortality and In-Hospital Adverse Events in Patients With Left Main Coronary Artery Disease. Innovations (Phila). 2009;4(2):80-5doi: 10.1097/IMI.0b013e3181a20da6.
Sarin, E. L., Puskas, J. D., Kilgo, P. D., Thourani, V. H., Guyton, R. A., & Lattouf, O. M. (2009). Off-Pump Coronary Artery Bypass Grafting is Associated With Reduced Operative Mortality and In-Hospital Adverse Events in Patients With Left Main Coronary Artery Disease. Innovations (Philadelphia, Pa.), 4(2), 80-5. https://doi.org/10.1097/IMI.0b013e3181a20da6
Sarin, Eric L, et al. "Off-Pump Coronary Artery Bypass Grafting is Associated With Reduced Operative Mortality and In-Hospital Adverse Events in Patients With Left Main Coronary Artery Disease." Innovations (Philadelphia, Pa.) vol. 4,2 (2009): 80-5. doi: https://doi.org/10.1097/IMI.0b013e3181a20da6
Sarin EL, Puskas JD, Kilgo PD, Thourani VH, Guyton RA, Lattouf OM. Off-Pump Coronary Artery Bypass Grafting is Associated With Reduced Operative Mortality and In-Hospital Adverse Events in Patients With Left Main Coronary Artery Disease. Innovations (Phila). 2009 Mar;4(2):80-5. doi: 10.1097/IMI.0b013e3181a20da6. PMID: 22436988.
Copy Download .nbib Format: NLM
Intraoperative epiaortic ultrasound scanning guides operative strategies and identifies patients at high risk during coronary artery bypass grafting.

Innovations (Philadelphia, Pa.)

Lyons JM, Thourani VH, Puskas JD, Kilgo PD, Baio KT, Guyton RA, Lattouf OM.
PMID: 22436990
Innovations (Phila). 2009 Mar;4(2):99-105. doi: 10.1097/IMI.0b013e3181a3476f.

OBJECTIVE: : Epiaortic ultrasound (EU) reliably reveals ascending aortic atherosclerosis (AAA), allowing strategies to minimize the risk of embolization or plaque disruption during coronary artery bypass grafting. Our objective was to delineate if EU-guided intervention improved outcomes.METHODS: : Patients...

Cite
Lyons JM, Thourani VH, Puskas JD, et al. Intraoperative epiaortic ultrasound scanning guides operative strategies and identifies patients at high risk during coronary artery bypass grafting. Innovations (Phila). 2009;4(2):99-105doi: 10.1097/IMI.0b013e3181a3476f.
Lyons, J. M., Thourani, V. H., Puskas, J. D., Kilgo, P. D., Baio, K. T., Guyton, R. A., & Lattouf, O. M. (2009). Intraoperative epiaortic ultrasound scanning guides operative strategies and identifies patients at high risk during coronary artery bypass grafting. Innovations (Philadelphia, Pa.), 4(2), 99-105. https://doi.org/10.1097/IMI.0b013e3181a3476f
Lyons, Jefferson M, et al. "Intraoperative epiaortic ultrasound scanning guides operative strategies and identifies patients at high risk during coronary artery bypass grafting." Innovations (Philadelphia, Pa.) vol. 4,2 (2009): 99-105. doi: https://doi.org/10.1097/IMI.0b013e3181a3476f
Lyons JM, Thourani VH, Puskas JD, Kilgo PD, Baio KT, Guyton RA, Lattouf OM. Intraoperative epiaortic ultrasound scanning guides operative strategies and identifies patients at high risk during coronary artery bypass grafting. Innovations (Phila). 2009 Mar;4(2):99-105. doi: 10.1097/IMI.0b013e3181a3476f. PMID: 22436990.
Copy Download .nbib Format: NLM
Cerebral Emboli Generation During Off-Pump Coronary Artery Bypass Grafting With a Clampless Device versus Partial Clamping of the Ascending Aorta.

Innovations (Philadelphia, Pa.)

Eldaif SM, Thourani VH, Puskas JD.
PMID: 22437269
Innovations (Phila). 2010 Jan;5(1):7-11. doi: 10.1097/IMI.0b013e3181cf897d.

OBJECTIVE: : It is not known whether use of a clampless facilitating device during proximal graft anastamosis decreases intraoperative cerebral emboli in patients with mild atherosclerotic ascending aorta (AAA) having off-pump coronary artery bypass.METHODS: : After intraoperative epiaortic ultrasound...

Cite
Eldaif SM, Thourani VH, Puskas JD. Cerebral Emboli Generation During Off-Pump Coronary Artery Bypass Grafting With a Clampless Device versus Partial Clamping of the Ascending Aorta. Innovations (Phila). 2010;5(1):7-11doi: 10.1097/IMI.0b013e3181cf897d.
Eldaif, S. M., Thourani, V. H., & Puskas, J. D. (2010). Cerebral Emboli Generation During Off-Pump Coronary Artery Bypass Grafting With a Clampless Device versus Partial Clamping of the Ascending Aorta. Innovations (Philadelphia, Pa.), 5(1), 7-11. https://doi.org/10.1097/IMI.0b013e3181cf897d
Eldaif, Shady M, et al. "Cerebral Emboli Generation During Off-Pump Coronary Artery Bypass Grafting With a Clampless Device versus Partial Clamping of the Ascending Aorta." Innovations (Philadelphia, Pa.) vol. 5,1 (2010): 7-11. doi: https://doi.org/10.1097/IMI.0b013e3181cf897d
Eldaif SM, Thourani VH, Puskas JD. Cerebral Emboli Generation During Off-Pump Coronary Artery Bypass Grafting With a Clampless Device versus Partial Clamping of the Ascending Aorta. Innovations (Phila). 2010 Jan;5(1):7-11. doi: 10.1097/IMI.0b013e3181cf897d. PMID: 22437269.
Copy Download .nbib Format: NLM
Third-generation continuous flow left ventricular assist devices.

Innovations (Philadelphia, Pa.)

Nguyen DQ, Thourani VH.
PMID: 22437454
Innovations (Phila). 2010 Jul-Aug;5(4):250-8. doi: 10.1097/IMI.0b013e3181ee77a1.

Tremendous advances have been made in the treatment of end-stage heart failure patients with left ventricular assist devices (LVADs). An important factor playing a role in the improved clinical outcomes is the development of continuous flow, rotary LVADs. New...

Cite
Nguyen DQ, Thourani VH. Third-generation continuous flow left ventricular assist devices. Innovations (Phila). 2010;5(4):250-8doi: 10.1097/IMI.0b013e3181ee77a1.
Nguyen, D. Q., & Thourani, V. H. (2010). Third-generation continuous flow left ventricular assist devices. Innovations (Philadelphia, Pa.), 5(4), 250-8. https://doi.org/10.1097/IMI.0b013e3181ee77a1
Nguyen, Duc Q, and Thourani, Vinod H. "Third-generation continuous flow left ventricular assist devices." Innovations (Philadelphia, Pa.) vol. 5,4 (2010): 250-8. doi: https://doi.org/10.1097/IMI.0b013e3181ee77a1
Nguyen DQ, Thourani VH. Third-generation continuous flow left ventricular assist devices. Innovations (Phila). 2010 Jul-Aug;5(4):250-8. doi: 10.1097/IMI.0b013e3181ee77a1. PMID: 22437454.
Copy Download .nbib Format: NLM
Off-Pump Coronary Artery Bypass Grafting is Associated With Reduced Operative Mortality and In-Hospital Adverse Events in Patients With Left Main Coronary Artery Disease.

Innovations (Philadelphia, Pa.)

Sarin EL, Puskas JD, Kilgo PD, Thourani VH, Guyton RA, Lattouf OM.
PMID: 22436988
Innovations (Phila). 2009 Mar;4(2):80-5. doi: 10.1097/IMI.0b013e3181a20da6.

OBJECTIVE: : Left main coronary artery disease (LMD) is a known risk factor for perioperative complications. This study compares off-pump coronary artery bypass (OPCAB) versus on-pump coronary artery bypass (ONCAB) grafting, CABG, with respect to in-hospital death, stroke, myocardial...

Cite
Sarin EL, Puskas JD, Kilgo PD, et al. Off-Pump Coronary Artery Bypass Grafting is Associated With Reduced Operative Mortality and In-Hospital Adverse Events in Patients With Left Main Coronary Artery Disease. Innovations (Phila). 2009;4(2):80-5doi: 10.1097/IMI.0b013e3181a20da6.
Sarin, E. L., Puskas, J. D., Kilgo, P. D., Thourani, V. H., Guyton, R. A., & Lattouf, O. M. (2009). Off-Pump Coronary Artery Bypass Grafting is Associated With Reduced Operative Mortality and In-Hospital Adverse Events in Patients With Left Main Coronary Artery Disease. Innovations (Philadelphia, Pa.), 4(2), 80-5. https://doi.org/10.1097/IMI.0b013e3181a20da6
Sarin, Eric L, et al. "Off-Pump Coronary Artery Bypass Grafting is Associated With Reduced Operative Mortality and In-Hospital Adverse Events in Patients With Left Main Coronary Artery Disease." Innovations (Philadelphia, Pa.) vol. 4,2 (2009): 80-5. doi: https://doi.org/10.1097/IMI.0b013e3181a20da6
Sarin EL, Puskas JD, Kilgo PD, Thourani VH, Guyton RA, Lattouf OM. Off-Pump Coronary Artery Bypass Grafting is Associated With Reduced Operative Mortality and In-Hospital Adverse Events in Patients With Left Main Coronary Artery Disease. Innovations (Phila). 2009 Mar;4(2):80-5. doi: 10.1097/IMI.0b013e3181a20da6. PMID: 22436988.
Copy Download .nbib Format: NLM
Reply.

The Annals of thoracic surgery

Condado JF, Thourani VH.
PMID: 28838493
Ann Thorac Surg. 2017 Sep;104(3):1097. doi: 10.1016/j.athoracsur.2017.01.017.

No abstract available.

Cite
Condado JF, Thourani VH. Reply. Ann Thorac Surg. 2017;104(3):1097doi: 10.1016/j.athoracsur.2017.01.017.
Condado, J. F., & Thourani, V. H. (2017). Reply. The Annals of thoracic surgery, 104(3), 1097. https://doi.org/10.1016/j.athoracsur.2017.01.017
Condado, Jose F, and Thourani, Vinod H. "Reply." The Annals of thoracic surgery vol. 104,3 (2017): 1097. doi: https://doi.org/10.1016/j.athoracsur.2017.01.017
Condado JF, Thourani VH. Reply. Ann Thorac Surg. 2017 Sep;104(3):1097. doi: 10.1016/j.athoracsur.2017.01.017. PMID: 28838493.
Copy Download .nbib Format: NLM
Predictors of Surgical Intervention in Dialysis Patients With Infective Endocarditis.

Open forum infectious diseases

Woller Iii JA, Walsh VL, Robichaux C, Thourani VH, Jacob JT.
PMID: 30539033
Open Forum Infect Dis. 2018 Oct 20;5(11):ofy265. doi: 10.1093/ofid/ofy265. eCollection 2018 Nov.

BACKGROUND: The use of valve surgery for infective endocarditis (IE) in end-stage renal disease (ESRD) patients may be different than in the general population. We assessed predictors of early surgery in ESRD patients with IE.METHODS: We conducted a retrospective...

Cite
Woller Iii JA, Walsh VL, Robichaux C, et al. Predictors of Surgical Intervention in Dialysis Patients With Infective Endocarditis. Open Forum Infect Dis. 2018;5(11):ofy265doi: 10.1093/ofid/ofy265.
Woller Iii, J. A., Walsh, V. L., Robichaux, C., Thourani, V. H., & Jacob, J. T. (2018). Predictors of Surgical Intervention in Dialysis Patients With Infective Endocarditis. Open forum infectious diseases, 5(11), ofy265. https://doi.org/10.1093/ofid/ofy265
Woller Iii, John A, et al. "Predictors of Surgical Intervention in Dialysis Patients With Infective Endocarditis." Open forum infectious diseases vol. 5,11 (2018): ofy265. doi: https://doi.org/10.1093/ofid/ofy265
Woller Iii JA, Walsh VL, Robichaux C, Thourani VH, Jacob JT. Predictors of Surgical Intervention in Dialysis Patients With Infective Endocarditis. Open Forum Infect Dis. 2018 Oct 20;5(11):ofy265. doi: 10.1093/ofid/ofy265. eCollection 2018 Nov. PMID: 30539033; PMCID: PMC6280940.
Copy Download .nbib Format: NLM
Long-term outcomes of aortic root operations in the United States among Medicare beneficiaries.

The Journal of thoracic and cardiovascular surgery

Yerokun BA, Vallabhajosyula P, Vekstein AM, Grau-Sepulveda MV, Benrashid E, Xian Y, Ranney DN, Jung SH, Jacobs JP, Badhwar V, Thourani VH, Bavaria JE, Hughes GC.
PMID: 33814173
J Thorac Cardiovasc Surg. 2021 Feb 25; doi: 10.1016/j.jtcvs.2021.02.068. Epub 2021 Feb 25.

OBJECTIVE: The best method of aortic root repair in older patients remains unknown given a lack of comparative effectiveness of long-term outcomes data. The objective of this study was to compare long-term outcomes of different surgical approaches for aortic...

Cite
Yerokun BA, Vallabhajosyula P, Vekstein AM, et al. Long-term outcomes of aortic root operations in the United States among Medicare beneficiaries. J Thorac Cardiovasc Surg. 2021;doi: 10.1016/j.jtcvs.2021.02.068.
Yerokun, B. A., Vallabhajosyula, P., Vekstein, A. M., Grau-Sepulveda, M. V., Benrashid, E., Xian, Y., Ranney, D. N., Jung, S. H., Jacobs, J. P., Badhwar, V., Thourani, V. H., Bavaria, J. E., & Hughes, G. C. (2021). Long-term outcomes of aortic root operations in the United States among Medicare beneficiaries. The Journal of thoracic and cardiovascular surgery, . https://doi.org/10.1016/j.jtcvs.2021.02.068
Yerokun, Babatunde A, et al. "Long-term outcomes of aortic root operations in the United States among Medicare beneficiaries." The Journal of thoracic and cardiovascular surgery vol. (2021). doi: https://doi.org/10.1016/j.jtcvs.2021.02.068
Yerokun BA, Vallabhajosyula P, Vekstein AM, Grau-Sepulveda MV, Benrashid E, Xian Y, Ranney DN, Jung SH, Jacobs JP, Badhwar V, Thourani VH, Bavaria JE, Hughes GC. Long-term outcomes of aortic root operations in the United States among Medicare beneficiaries. J Thorac Cardiovasc Surg. 2021 Feb 25; doi: 10.1016/j.jtcvs.2021.02.068. Epub 2021 Feb 25. PMID: 33814173.
Copy Download .nbib Format: NLM
Commentary: Younger patients are choosing tissue valves: Do the data match their fervor?.

The Journal of thoracic and cardiovascular surgery

Forcillo J, Thourani VH.
PMID: 33745711
J Thorac Cardiovasc Surg. 2021 Feb 24; doi: 10.1016/j.jtcvs.2021.02.061. Epub 2021 Feb 24.

No abstract available.

Cite
Forcillo J, Thourani VH. Commentary: Younger patients are choosing tissue valves: Do the data match their fervor?. J Thorac Cardiovasc Surg. 2021;doi: 10.1016/j.jtcvs.2021.02.061.
Forcillo, J., & Thourani, V. H. (2021). Commentary: Younger patients are choosing tissue valves: Do the data match their fervor?. The Journal of thoracic and cardiovascular surgery, . https://doi.org/10.1016/j.jtcvs.2021.02.061
Forcillo, Jessica, and Thourani, Vinod H. "Commentary: Younger patients are choosing tissue valves: Do the data match their fervor?." The Journal of thoracic and cardiovascular surgery vol. (2021). doi: https://doi.org/10.1016/j.jtcvs.2021.02.061
Forcillo J, Thourani VH. Commentary: Younger patients are choosing tissue valves: Do the data match their fervor?. J Thorac Cardiovasc Surg. 2021 Feb 24; doi: 10.1016/j.jtcvs.2021.02.061. Epub 2021 Feb 24. PMID: 33745711.
Copy Download .nbib Format: NLM
Neosinus and Sinus Flow After Self-Expanding and Balloon-Expandable Transcatheter Aortic Valve Replacement.

JACC. Cardiovascular interventions

Hatoum H, Gooden SCM, Sathananthan J, Sellers S, Kutting M, Marx P, Lilly SM, Ihdayhid AR, Thourani VH, Dasi LP.
PMID: 34838462
JACC Cardiovasc Interv. 2021 Nov 17; doi: 10.1016/j.jcin.2021.09.013. Epub 2021 Nov 17.

OBJECTIVES: The aim of this study was to evaluate flow dynamics in the aortic sinus and the neosinus (NS) after transcatheter heart valve (THV) implantation in valve-in-valve (ViV).BACKGROUND: Leaflet thrombosis may occur on THVs and affect performance and durability....

Cite
Hatoum H, Gooden SCM, Sathananthan J, et al. Neosinus and Sinus Flow After Self-Expanding and Balloon-Expandable Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2021;doi: 10.1016/j.jcin.2021.09.013.
Hatoum, H., Gooden, S. C. M., Sathananthan, J., Sellers, S., Kutting, M., Marx, P., Lilly, S. M., Ihdayhid, A. R., Thourani, V. H., & Dasi, L. P. (2021). Neosinus and Sinus Flow After Self-Expanding and Balloon-Expandable Transcatheter Aortic Valve Replacement. JACC. Cardiovascular interventions, . https://doi.org/10.1016/j.jcin.2021.09.013
Hatoum, Hoda, et al. "Neosinus and Sinus Flow After Self-Expanding and Balloon-Expandable Transcatheter Aortic Valve Replacement." JACC. Cardiovascular interventions vol. (2021). doi: https://doi.org/10.1016/j.jcin.2021.09.013
Hatoum H, Gooden SCM, Sathananthan J, Sellers S, Kutting M, Marx P, Lilly SM, Ihdayhid AR, Thourani VH, Dasi LP. Neosinus and Sinus Flow After Self-Expanding and Balloon-Expandable Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2021 Nov 17; doi: 10.1016/j.jcin.2021.09.013. Epub 2021 Nov 17. PMID: 34838462.
Copy Download .nbib Format: NLM
Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose.

American heart journal

Gibson CM, Mack MJ, Lee VT, Schneider DJ, Sellke FW, Ohman EM, Thourani VH, Doros G, Kroger H, Cutlip DE, Deliargyris EN.
PMID: 34736855
Am Heart J. 2021 Nov 01;245:19-28. doi: 10.1016/j.ahj.2021.10.188. Epub 2021 Nov 01.

BACKGROUND: Ticagrelor is often administered to patients with acute coronary syndromes. However, when these patients require urgent or emergent cardiothoracic (CT) surgery the presence of ticagrelor significantly increases surgical bleeding. The goal of the current trial is to evaluate...

Cite
Gibson CM, Mack MJ, Lee VT, et al. Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose. Am Heart J. 2021;245:19-28doi: 10.1016/j.ahj.2021.10.188.
Gibson, C. M., Mack, M. J., Lee, V. T., Schneider, D. J., Sellke, F. W., Ohman, E. M., Thourani, V. H., Doros, G., Kroger, H., Cutlip, D. E., & Deliargyris, E. N. (2021). Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose. American heart journal, 24519-28. https://doi.org/10.1016/j.ahj.2021.10.188
Gibson, C Michael, et al. "Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose." American heart journal vol. 245 (2021): 19-28. doi: https://doi.org/10.1016/j.ahj.2021.10.188
Gibson CM, Mack MJ, Lee VT, Schneider DJ, Sellke FW, Ohman EM, Thourani VH, Doros G, Kroger H, Cutlip DE, Deliargyris EN. Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose. Am Heart J. 2021 Nov 01;245:19-28. doi: 10.1016/j.ahj.2021.10.188. Epub 2021 Nov 01. PMID: 34736855.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 123 entries